Genesco Balance Sheet Health
Financial Health criteria checks 4/6
Genesco has a total shareholder equity of $516.9M and total debt of $100.1M, which brings its debt-to-equity ratio to 19.4%. Its total assets and total liabilities are $1.4B and $918.6M respectively. Genesco's EBIT is $7.4M making its interest coverage ratio 1.5. It has cash and short-term investments of $33.6M.
Key information
19.4%
Debt to equity ratio
US$100.11m
Debt
| Interest coverage ratio | 1.5x |
| Cash | US$33.58m |
| Equity | US$516.90m |
| Total liabilities | US$918.62m |
| Total assets | US$1.44b |
Recent financial health updates
Is Genesco (NYSE:GCO) Using Too Much Debt?
Nov 13
Genesco (NYSE:GCO) Seems To Be Using A Lot Of Debt
Nov 04Is Genesco (NYSE:GCO) A Risky Investment?
Sep 27These 4 Measures Indicate That Genesco (NYSE:GCO) Is Using Debt Reasonably Well
Jun 13Recent updates
Optimistic Investors Push Genesco Inc. (NYSE:GCO) Shares Up 31% But Growth Is Lacking
Nov 26Is Genesco (NYSE:GCO) Using Too Much Debt?
Nov 13Returns On Capital Signal Difficult Times Ahead For Genesco (NYSE:GCO)
Oct 18Genesco Q2: Underperforming Comparable Sales, As Wall Street Expected
Sep 07Genesco Inc.'s (NYSE:GCO) Shares Climb 31% But Its Business Is Yet to Catch Up
Aug 01The Returns On Capital At Genesco (NYSE:GCO) Don't Inspire Confidence
Jul 12Genesco's Assortment Bet For H2 2025 Is Risky, The Stock Is Still A Hold
Jun 30Genesco: Faces A Challenging Demand Environment
Mar 19Returns On Capital At Genesco (NYSE:GCO) Paint A Concerning Picture
Mar 09Genesco: Focus On Future Margin Trajectory
Feb 27Does This Valuation Of Genesco Inc. (NYSE:GCO) Imply Investors Are Overpaying?
Feb 13Genesco Inc.'s (NYSE:GCO) Shares May Have Run Too Fast Too Soon
Jan 04Genesco: Weak Results And Future Outlook
Dec 11Genesco (NYSE:GCO) Seems To Be Using A Lot Of Debt
Nov 04Should You Think About Buying Genesco Inc. (NYSE:GCO) Now?
Sep 11Genesco: Promising Initiatives, But Upside Is Limited
Sep 07Be Wary Of Genesco (NYSE:GCO) And Its Returns On Capital
Aug 26Genesco: Is It Too Soon To Buy This Cyclical?
Jun 14Genesco: Earnings Shocker, Initiate At Sell
May 26Should You Investigate Genesco Inc. (NYSE:GCO) At US$20.19?
May 26A Look At The Fair Value Of Genesco Inc. (NYSE:GCO)
May 05Returns On Capital Are Showing Encouraging Signs At Genesco (NYSE:GCO)
Nov 17Is It Too Late To Consider Buying Genesco Inc. (NYSE:GCO)?
Oct 27Genesco: Optimistic Management And Undervalued Stock
Oct 14Is Genesco (NYSE:GCO) A Risky Investment?
Sep 27Genesco FQ2 2023 Earnings Preview
Aug 31Returns On Capital Are Showing Encouraging Signs At Genesco (NYSE:GCO)
Aug 17Does Genesco (NYSE:GCO) Deserve A Spot On Your Watchlist?
Jul 01These 4 Measures Indicate That Genesco (NYSE:GCO) Is Using Debt Reasonably Well
Jun 13What Does Genesco Inc.'s (NYSE:GCO) Share Price Indicate?
May 31Financial Position Analysis
Short Term Liabilities: GCO's short term assets ($659.7M) exceed its short term liabilities ($422.1M).
Long Term Liabilities: GCO's short term assets ($659.7M) exceed its long term liabilities ($496.5M).
Debt to Equity History and Analysis
Debt Level: GCO's net debt to equity ratio (12.9%) is considered satisfactory.
Reducing Debt: GCO's debt to equity ratio has increased from 13.9% to 19.4% over the past 5 years.
Debt Coverage: GCO's debt is well covered by operating cash flow (89.1%).
Interest Coverage: GCO's interest payments on its debt are not well covered by EBIT (1.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 10:11 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/11/02 |
| Annual Earnings | 2024/02/03 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Genesco Inc. is covered by 17 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mark Montagna | Avondale Partners |
| Jonathan Komp | Baird |
| Corinna Freedman | BB&T Capital Markets |